More than 70 years ago, Dr.
Sidney Farber refused to accept that childhood cancer was untreatable, and his
determination led to the development of chemotherapy and the first remissions
of childhood leukemia.
Today, we continue Dr. Farber’s legacy through research that has yielded many of the advances in care
used today. Here are some highlights of our team’s long history of accomplishments:
Not only are we a top cancer and blood disease center, we're also a top pediatric hospital. Above, our physicians explain how our vast clinical resources benefit patients.
Through clinical trials and research, Dana-Farber/Boston Children's is at the forefront of innovative treatments, including gene therapy.
Precision cancer medicine provides individualized treatment tailored to the specific genetic characteristics of a patient's cancer. Our research and clinical trials are leading the way in precision medicine for pediatric cancer.